132 related articles for article (PubMed ID: 15665864)
1. Effects of minocycline on Fas-mediated fulminant hepatitis in mice.
Chu HC; Lin YL; Sytwu HK; Lin SH; Liao CL; Chao YC
Br J Pharmacol; 2005 Jan; 144(2):275-82. PubMed ID: 15665864
[TBL] [Abstract][Full Text] [Related]
2. Edaravone prevents Fas-induced fulminant hepatic failure in mice by regulating mitochondrial Bcl-xL and Bax.
Miyasou T; Kwon AH; Tsuji K; Qiu Z; Okumura T; Kamiyama Y
Shock; 2008 Aug; 30(2):212-6. PubMed ID: 18180697
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation.
Cazanave S; Vadrot N; Tinel M; Berson A; Lettéron P; Larosche I; Descatoire V; Feldmann G; Robin MA; Pessayre D
Toxicol Appl Pharmacol; 2008 Sep; 231(3):336-43. PubMed ID: 18572215
[TBL] [Abstract][Full Text] [Related]
4. High hepatic glutathione stores alleviate Fas-induced apoptosis in mice.
Cazanave S; Berson A; Haouzi D; Vadrot N; Fau D; Grodet A; Lettéron P; Feldmann G; El-Benna J; Fromenty B; Robin MA; Pessayre D
J Hepatol; 2007 May; 46(5):858-68. PubMed ID: 17275124
[TBL] [Abstract][Full Text] [Related]
5. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody.
Feng G; Kaplowitz N
J Clin Invest; 2000 Feb; 105(3):329-39. PubMed ID: 10675359
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the apelin receptor APJ in Fas-induced liver injury.
Yasuzaki H; Yoshida S; Hashimoto T; Shibata W; Inamori M; Toya Y; Tamura K; Maeda S; Umemura S
Liver Int; 2013 Jan; 33(1):118-26. PubMed ID: 23121371
[TBL] [Abstract][Full Text] [Related]
7. Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/Bax-deficient mice.
Hikita H; Takehara T; Kodama T; Shimizu S; Shigekawa M; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Shimizu S; Tsujimoto Y; Hayashi N
Hepatology; 2011 Jul; 54(1):240-51. PubMed ID: 21425311
[TBL] [Abstract][Full Text] [Related]
8. Fulminant liver failure triggered by therapeutic antibody treatment in a mouse model.
Matsuda Y; Toda M; Kato T; Kuribayashi K; Kakimi K
Int J Oncol; 2006 Nov; 29(5):1119-25. PubMed ID: 17016642
[TBL] [Abstract][Full Text] [Related]
9. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice.
Wang X; Lu Y; Cederbaum AI
Hepatology; 2005 Aug; 42(2):400-10. PubMed ID: 16025513
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor reduces Fas-mediated acute liver injury in mice.
Tanaka Y; Sohda T; Matsuo K; Anan A; Irie M; Takeyama Y; Iwata K; Shakado S; Sakisaka S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e207-11. PubMed ID: 17784864
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
13. Hepatic platelet accumulation in Fas-mediated hepatitis in mice.
Ohtaki Y; Yamaguchi K; Yu Z; Kumamoto H; Shimauchi H; Iwakura Y; Sugawara S; Endo Y
Int Immunopharmacol; 2009 Aug; 9(9):1071-8. PubMed ID: 19439197
[TBL] [Abstract][Full Text] [Related]
14. Differential caspase-9-dependent signaling pathway between tumor necrosis factor receptor- and Fas-mediated hepatocyte apoptosis in mice.
Imao M; Nagaki M; Imose M; Moriwaki H
Liver Int; 2006 Feb; 26(1):137-46. PubMed ID: 16420519
[TBL] [Abstract][Full Text] [Related]
15. Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.
Matsuki Y; Li L; Hsu HC; Yang PA; Zheng R; Edwards CK; Chaudry IH; Zhang HG; Mountz JD
Cell Death Differ; 2002 Jun; 9(6):626-35. PubMed ID: 12032671
[TBL] [Abstract][Full Text] [Related]
16. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
17. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms.
Haga S; Terui K; Zhang HQ; Enosawa S; Ogawa W; Inoue H; Okuyama T; Takeda K; Akira S; Ogino T; Irani K; Ozaki M
J Clin Invest; 2003 Oct; 112(7):989-98. PubMed ID: 14523036
[TBL] [Abstract][Full Text] [Related]
18. TAT-apoptosis repressor with caspase recruitment domain protein transduction rescues mice from fulminant liver failure.
An J; Harms C; Lättig-Tünnemann G; Sellge G; Mandić AD; Malato Y; Heuser A; Endres M; Trautwein C; Donath S
Hepatology; 2012 Aug; 56(2):715-26. PubMed ID: 22392694
[TBL] [Abstract][Full Text] [Related]
19. Rat hepatocyte engraftment in severe combined immunodeficient x beige mice using mouse-specific anti-fas antibody.
Wilson JH; Paturzo FX; Johnson LK; Carreiro MP; Hixson DC; Mennone A; Boyer JL; Pober JS; Harding MJ
Xenotransplantation; 2006 Jan; 13(1):53-62. PubMed ID: 16497212
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholyl Lysophosphatidylethanolamide Protects Against CD95/FAS-Induced Fulminant Hepatitis.
Utaipan T; Otto AC; Gan-Schreier H; Chunglok W; Pathil A; Stremmel W; Chamulitrat W
Shock; 2017 Aug; 48(2):251-259. PubMed ID: 28060213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
